The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aerovate Therapeutics, Inc. | COMM | 008064107 | 85,811 | 3,758,686 | SH | SOLE | 3,758,686 | 0 | 0 | ||
Akouos, Inc | COMM | 00973J101 | 19,014 | 1,515,074 | SH | SOLE | 1,515,074 | 0 | 0 | ||
Amarin Corp | ADR | 023111206 | 5,127 | 1,170,584 | SH | SOLE | 1,170,584 | 0 | 0 | ||
Ascendis Pharma A/S | ADR | 04351P101 | 68,659 | 521,923 | SH | SOLE | 521,923 | 0 | 0 | ||
Bolt Biotherapeutics, Inc. | COMM | 097702104 | 42,584 | 2,754,437 | SH | SOLE | 2,754,437 | 0 | 0 | ||
Checkmate Pharmaceuticals Inc | COMM | 162818108 | 21,496 | 3,606,707 | SH | SOLE | 3,606,707 | 0 | 0 | ||
Coherus BioSciences | COMM | 19249H103 | 6,010 | 434,555 | SH | SOLE | 434,555 | 0 | 0 | ||
Galera Therapeutics, Inc | COMM | 36338D108 | 30,313 | 3,083,712 | SH | SOLE | 3,083,712 | 0 | 0 | ||
Inozyme Pharma, Inc. | COMM | 45790W108 | 34,562 | 2,028,308 | SH | SOLE | 2,028,308 | 0 | 0 | ||
Karuna Therapeutics, Inc. | COMM | 48576A100 | 222,559 | 1,952,441 | SH | SOLE | 1,952,441 | 0 | 0 | ||
Natera | COMM | 632307104 | 352,007 | 3,100,560 | SH | SOLE | 3,100,560 | 0 | 0 | ||
Nextcure, Inc | COMM | 65343E108 | 21,455 | 2,671,856 | SH | SOLE | 2,671,856 | 0 | 0 | ||
Nucana Biomed Ltd | ADR | 67022C106 | 15,512 | 5,599,999 | SH | SOLE | 5,599,999 | 0 | 0 | ||
Nucana Biomed Ltd | Ordinary Shares | GB00BYWYV | 6,648 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
ObsEva SA | COMM | H5861P103 | 14,391 | 4,749,623 | SH | SOLE | 4,749,623 | 0 | 0 | ||
PDS Biotechnology Corporation | COMM | 70465T107 | 1,790 | 142,635 | SH | SOLE | 142,635 | 0 | 0 | ||
Synlogic Inc. | COMM | 87166L100 | 2,237 | 574,972 | SH | SOLE | 574,972 | 0 | 0 | ||
Vera Therapeutics, Inc. | CL A | 92337R101 | 38,650 | 2,914,776 | SH | SOLE | 2,914,776 | 0 | 0 | ||
Y-mAbs Therapeutics, Inc | COMM | 984241109 | 74,167 | 2,194,278 | SH | SOLE | 2,194,278 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc | COMM | 004225908 | 2,439 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
ARK ETF TR | Genomic Rev ETF | 00214Q952 | 23,125 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | |
Acceleron Pharma Inc | COMM | 00434H108 | 29,319 | 233,638 | SH | SOLE | 233,638 | 0 | 0 | ||
Agenus Inc | COMM | 00847G705 | 15,207 | 2,769,900 | SH | SOLE | 2,769,900 | 0 | 0 | ||
Agios Pharmaceuticals, Inc. | COMM | 00847X104 | 12,071 | 219,033 | SH | SOLE | 219,033 | 0 | 0 | ||
Align Technology Inc | COMM | 016255101 | 28,774 | 47,093 | SH | SOLE | 47,093 | 0 | 0 | ||
Aligos Therapeutics Inc | COMM | 01626L105 | 3,344 | 164,051 | SH | SOLE | 164,051 | 0 | 0 | ||
Amgen Inc | COMM | 031162100 | 9,872 | 40,500 | SH | SOLE | 40,500 | 0 | 0 | ||
AstraZeneca PLC | ADR | 046353108 | 57,482 | 959,632 | SH | SOLE | 959,632 | 0 | 0 | ||
BioCryst Pharmaceuticals Inc | COMM | 09058V103 | 2,508 | 158,609 | SH | SOLE | 158,609 | 0 | 0 | ||
Biogen Inc | COMM | 09062X103 | 38,297 | 110,600 | SH | SOLE | 110,600 | 0 | 0 | ||
CTI BioPharma Corp | COMM | 12648L601 | 429 | 171,619 | SH | SOLE | 171,619 | 0 | 0 | ||
Celldex Therapeutics, Inc. | COMM | 15117B202 | 4,505 | 134,724 | SH | SOLE | 134,724 | 0 | 0 | ||
ChemoCentryx Inc | COMM | 16383L906 | 2,879 | 215,000 | SH | Call | SOLE | 215,000 | 0 | 0 | |
ChemoCentryx Inc | COMM | 16383L106 | 6,235 | 465,637 | SH | SOLE | 465,637 | 0 | 0 | ||
Cyteir Therapeutics, Inc. | COMM | 23284P103 | 5,671 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
Cytokinetics Inc | COMM | 23282W605 | 9,525 | 481,323 | SH | SOLE | 481,323 | 0 | 0 | ||
Dexcom Inc | COMM | 252131107 | 14,395 | 33,713 | SH | SOLE | 33,713 | 0 | 0 | ||
Exelixis Inc | COMM | 30161Q104 | 19,672 | 1,079,681 | SH | SOLE | 1,079,681 | 0 | 0 | ||
Fate Therapeutics Inc | COMM | 31189P102 | 4,026 | 46,386 | SH | SOLE | 46,386 | 0 | 0 | ||
FibroGen, Inc. | COMM | 31572Q958 | 5,326 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
Heron Therapeutics Inc | COMM | 427746102 | 22,778 | 1,467,675 | SH | SOLE | 1,467,675 | 0 | 0 | ||
Immatics NV | COMM | N44445109 | 5,148 | 443,370 | SH | SOLE | 443,370 | 0 | 0 | ||
Insmed Inc | COMM | 457669307 | 24,025 | 844,169 | SH | SOLE | 844,169 | 0 | 0 | ||
Insulet Corp | COMM | 45784P101 | 18,804 | 68,500 | SH | SOLE | 68,500 | 0 | 0 | ||
Intra-Cellular Therapies Inc | COMM | 46116X101 | 12,783 | 313,159 | SH | SOLE | 313,159 | 0 | 0 | ||
iShares TR | iShares Biotech | 464287956 | 53,186 | 325,000 | SH | Put | SOLE | 325,000 | 0 | 0 | |
Jounce Therapeutics Inc | COMM | 481116101 | 4,248 | 624,756 | SH | SOLE | 624,756 | 0 | 0 | ||
Kura Oncology Inc | COMM | 50127T109 | 9,265 | 444,372 | SH | SOLE | 444,372 | 0 | 0 | ||
MacroGenics Inc | COMM | 556099109 | 6,299 | 234,504 | SH | SOLE | 234,504 | 0 | 0 | ||
Marinus Pharmaceuticals Inc | COMM | 56854Q200 | 6,210 | 346,160 | SH | SOLE | 346,160 | 0 | 0 | ||
Mirati Therapeutics Inc | COMM | 60468T105 | 12,686 | 78,538 | SH | SOLE | 78,538 | 0 | 0 | ||
Mirum Pharmaceuticals Inc | COMM | 604749101 | 4,486 | 259,465 | SH | SOLE | 259,465 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | COMM | 64125C109 | 19,775 | 203,200 | SH | SOLE | 203,200 | 0 | 0 | ||
Otonomy Inc | COMM | 68906L105 | 2,790 | 1,251,256 | SH | SOLE | 1,251,256 | 0 | 0 | ||
PTC Therapeutics Inc | COMM | 69366J200 | 24,599 | 581,940 | SH | SOLE | 581,940 | 0 | 0 | ||
Protagonist Therapeutics Inc | COMM | 74366E102 | 20,155 | 449,082 | SH | SOLE | 449,082 | 0 | 0 | ||
Reata Pharmaceuticals Inc | COMM | 75615P103 | 11,266 | 79,601 | SH | SOLE | 79,601 | 0 | 0 | ||
Regenxbio Inc | COMM | 75901B107 | 16,618 | 427,740 | SH | SOLE | 427,740 | 0 | 0 | ||
Replimune Group Inc | COMM | 76029N106 | 2,753 | 71,661 | SH | SOLE | 71,661 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | COMM | 803607100 | 23,205 | 298,500 | SH | SOLE | 298,500 | 0 | 0 | ||
Savara Inc | COMM | 805111101 | 2,173 | 1,278,424 | SH | SOLE | 1,278,424 | 0 | 0 | ||
Sierra Oncology, Inc. | COMM | 82640U404 | 49 | 2,500 | SH | SOLE | 2,500 | 0 | 0 | ||
TCR2 Therapeutics Inc | COMM | 87808K956 | 2,292 | 139,700 | SH | Put | SOLE | 139,700 | 0 | 0 | |
TCR2 Therapeutics Inc | COMM | 87808K106 | 4,862 | 296,282 | SH | SOLE | 296,282 | 0 | 0 | ||
Uniqure NV | COMM | N90064101 | 9,989 | 324,303 | SH | SOLE | 324,303 | 0 | 0 | ||
United Therapeutics Corp | COMM | 91307C102 | 38,768 | 216,085 | SH | SOLE | 216,085 | 0 | 0 | ||
Vertex Pharmaceuticals Inc | COMM | 92532F100 | 17,787 | 88,214 | SH | SOLE | 88,214 | 0 | 0 |